Ryoichi Sugisawa

Scopus Author ID Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Venues

Cell death & disease

Scientific reports

Urolithiasis

Tokyo Daigaku

Tokyo Daigaku (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tokyo Daigaku Apr 01 2017 - Nov 30 2017

Japan

Project Assistant Professor :: Endowed Laboratory for New Generation Drug Discovery, Faculty of Medicine

Education History

Tokyo Daigaku Apr 01 2013 - Mar 23 2017

Japan

PHD :: Faculty of Medicine

Nippon Veterinary and Life Science University

Japan

BSC :: School of Veterinary Medicine, Faculty of Veterinary Science

Publications

Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (2) (2024)
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (2) (2024)
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (2) (2024)
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Correction: Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (5) (2024)
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Correction: Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (5) (2024)
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (2) (2024)
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (2) (2024)
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (2) (2024)
Suman Dash, Takeshi Ueda, Akiyoshi Komuro, Masahiko Honda, Ryoichi Sugisawa, Hitoshi Okada
Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Cell death & disease 15 (2) (2024)
Masaki Watanabe, Ryo Ando, Ryoichi Sugisawa, Nobuya Sasaki, Satomi Iwai
A novel in vivo model of ureteral fibrosis induced by calcium oxalate beads in C57BL/6J mice. Urolithiasis 51 (1) (2023)
Ryoichi Sugisawa, Ginga Komatsu, Emiri Hiramoto, Naoki Takeda, Ken-Ichi Yamamura, Satoko Arai, Toru Miyazaki
Independent modes of disease repair by AIM protein distinguished in AIM-felinized mice. Scientific reports 8 (1) (2018)

Ryoichi Sugisawa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ryoichi Sugisawa